We are live on ! Find out more
IART icon

Integra LifeSciences
IART

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46% → 90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264 → 261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$140M
2
EVM
Eaton Vance Management
Massachusetts
+$75M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$25.7M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$20.8M
5
Morgan Stanley
Morgan Stanley
New York
+$14.4M

Top Sellers

1
CIP
Champlain Investment Partners
Vermont
-$55.3M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$35.3M
3
CB
Cooke & Bieler
Pennsylvania
-$26.1M
4
Norges Bank
Norges Bank
Norway
-$17.2M
5
Jennison Associates
Jennison Associates
New York
-$12.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCIA
176
Campbell & Co Investment Adviser
Maryland
$351K +$31.8K +450 +10%
CSS
177
Cubist Systematic Strategies
Connecticut
$346K -$823K -11,648 -70%
KCM
178
Karp Capital Management
California
$344K +$355K +5,025 New
CCA
179
Conestoga Capital Advisors
Pennsylvania
$342K – – –
MOS
180
MGO One Seven
Ohio
$340K – – –
Bessemer Group
181
Bessemer Group
New Jersey
$331K +$7.07K +100 +2%
CS
182
Cannell & Spears
New York
$328K – – –
PAMS
183
Pictet Asset Management (Switzerland)
Switzerland
$322K +$332K +4,700 New
NIC
184
Northwest Investment Counselors
Oregon
$300K – – –
PA
185
Profund Advisors
Maryland
$295K -$32K -453 -10%
GC
186
Guggenheim Capital
Illinois
$289K +$298K +4,217 New
CAPTRUST Financial Advisors
187
CAPTRUST Financial Advisors
North Carolina
$283K +$18.7K +265 +7%
BC
188
Burney Company
Virginia
$276K – – –
SLG
189
Stanley-Laman Group
Pennsylvania
$274K – – –
SCM
190
Shelton Capital Management
Colorado
$271K – – –
NICM
191
Neo Ivy Capital Management
New York
$267K +$402K +5,689 New
GT
192
Glenmede Trust
Pennsylvania
$253K -$22K -312 -8%
PAM
193
Panagora Asset Management
Massachusetts
$245K – – –
CT
194
Cambridge Trust
Massachusetts
$234K -$29.5K -417 -11%
CIBC Asset Management
195
CIBC Asset Management
Ontario, Canada
$233K +$21.4K +303 +10%
WT
196
Whittier Trust
California
$229K – – –
Susquehanna International Group
197
Susquehanna International Group
Pennsylvania
$226K +$233K +3,295 New
II
198
Inspire Investing
Idaho
$221K +$228K +3,234 New
ACI
199
AMP Capital Investors
Australia
$219K +$226K +3,200 New
XT
200
XTX Topco
Cayman Islands
$217K +$224K +3,175 New
6 7
8
9 10

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.